Suppr超能文献

慢性肾脏病和终末期肾病患者肠道微生物群的菌群多样性。

Diversity of family in gut microbiota of patients with chronic kidney disease and end stage renal disease.

作者信息

Amini Khiabani Siamak, Haghighat Setareh, Tayebi Khosroshahi Hamid, Asgharzadeh Mohammad, Samadi Kafil Hossein

机构信息

Department of Microbiology, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Health Promot Perspect. 2023 Sep 11;13(3):237-242. doi: 10.34172/hpp.2023.29. eCollection 2023.

Abstract

BACKGROUND

Human intestine microbiota are known to be directly and indirectly altered during some diseases such as kidney complications. Bacteroides is considered as the main and the most abundant phylum among human gut microbiota, which has been classified as enterotype 1. This study aimed to assess the abundance of Bacteroides spp. in fecal flora of end-stage renal disease (ESRD) and chronic kidney disease (CKD) patients and compare it with the Bacteroides composition among fecal flora of healthy individual.

METHODS

Fresh fecal samples were collected from 20 CKD/ESRD patients and 20 healthy individual without any kidney complications. The pure microbial DNA was extracted by QIAamp Stool Mini Kit from stool samples. MiSeq system was used to analyze the intestinal composition by next generation sequencing method.

RESULTS

A number of 651 bacterial strains were isolated and identified from 40 fecal samples of both patients and healthy groups. Bioinformatics analysis defined 18 different types of Bacteroides species which included 2.76% of all strains. Statistical analysis showed no significant difference between study groups (>0.05). In both healthy and patient groups three species including , , and have allocated the most abundance to themselves. The lowest abundance was related to , and among CKD/ESRD patients and , , and had the lowest abundance among healthy people.

CONCLUSION

This study indicates despite all previous evidence of role in gut microbiota, it had no different distribution between healthy persons and CKD/ESRD patients.

摘要

背景

已知人类肠道微生物群在某些疾病(如肾脏并发症)期间会直接或间接地发生改变。拟杆菌被认为是人类肠道微生物群中主要且最丰富的门类,已被归类为肠型1。本研究旨在评估终末期肾病(ESRD)和慢性肾病(CKD)患者粪便菌群中拟杆菌属的丰度,并将其与健康个体粪便菌群中的拟杆菌组成进行比较。

方法

从20例CKD/ESRD患者和20例无任何肾脏并发症的健康个体中收集新鲜粪便样本。使用QIAamp Stool Mini试剂盒从粪便样本中提取纯微生物DNA。采用MiSeq系统通过下一代测序方法分析肠道组成。

结果

从患者组和健康组的40份粪便样本中分离并鉴定出651株细菌菌株。生物信息学分析确定了18种不同类型的拟杆菌属物种,占所有菌株的2.76%。统计分析显示研究组之间无显著差异(>0.05)。在健康组和患者组中,包括[具体三种拟杆菌名称缺失]、[具体三种拟杆菌名称缺失]和[具体三种拟杆菌名称缺失]在内的三种拟杆菌属物种在各自群体中所占丰度最高。在CKD/ESRD患者中,[具体三种拟杆菌名称缺失]、[具体三种拟杆菌名称缺失]和[具体三种拟杆菌名称缺失]的丰度最低,而在健康人群中,[具体三种拟杆菌名称缺失]、[具体三种拟杆菌名称缺失]和[具体三种拟杆菌名称缺失]的丰度最低。

结论

本研究表明,尽管先前有证据表明[具体作用缺失]在肠道微生物群中发挥作用,但在健康人和CKD/ESRD患者之间其分布并无差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c40/10558969/73ef4eceec0b/hpp-13-237-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验